Images courtesy of Robert Koivula (University of Oxford)
DIRECT is an acronym for the project “DIabetes REsearCh on patient straTification and received support from the Innovative Medicines Initiative Joint Undertaking (IMI-JU) under grant agreement n° 115317, resources of which are composed of financial contribution from European Union`s Seventh Framework programme (FP7/2007-2013) and five EFPIA companies´ in kind contribution.
This website reflects only the author´s views and neither IMI nor the European Commission is liable for any use that may be made of the information contained therein.
The DIRECT project is supported by the Innovative Medicines Initiative (IMI), a large-scale public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) which as the names indicates is an association of pharmaceutical companies in Europe.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.